Eric G. Carter

Insider Reports History

Entity
Individual
Location
C/O King Pharmaceuticals, Inc., 501 Fifth Street, Bristol, TN
Signature
/s/ Alexander Wilson as attorney-in-fact for Eric G. Carter
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Eric G. Carter:

Stock Role Class Num Shares Value Price $ Report Date Ownership
AEON Biopharma, Inc. Director Stock Option 96.2K Aug 31, 2024 Direct
AEON Biopharma, Inc. Director Class A Common Stock 36K Aug 31, 2024 Direct
AEON Biopharma, Inc. Director Stock Option 8.13K Mar 19, 2024 Direct

Insider Reports Filed by Eric G. Carter

Symbol Company Period Transactions Value $ Form Type Date Filed Role
AEON AEON Biopharma, Inc. Aug 31, 2024 2 $0 4 Sep 4, 2024 Director
AEON AEON Biopharma, Inc. Mar 19, 2024 2 $0 4 Mar 21, 2024 Director
AEON AEON Biopharma, Inc. Aug 14, 2023 1 $0 4 Aug 16, 2023 Director
AEON AEON Biopharma, Inc. Jul 21, 2023 2 $0 4 Jul 24, 2023 Director
AEON AEON Biopharma, Inc. Jul 21, 2023 0 $0 3 Jul 24, 2023 Director